Evidence map›Paper›PMID 23359774›Full record

ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2012

XPC Polymorphism Increases Risk of Digestive System Cancers: Current Evidence from A Meta-Analysis.

Xia Jiang, Li-Tao Zhou, Shan-Chun Zhang, Kun Chen

Abstract read
In one paragraph

Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. The Role of DNA Repair (Medicina (Kaunas, Lithuania) · 2024
    Article
  3. Article
  4. Article
  5. Effect ofOncoTargets and therapy · 2019
    Article
  6. Article
  7. Article
  8. XPC intron11 C/A polymorphism as a risk factor for prostate cancer.Environmental health and preventive medicine · 2016
    Article
  9. Article
  10. Article
  11. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xia JiangDepartment of Epidemiology and Health Statistics, Zhejiang University School of Medicine, Hangzhou 310058, China.
Li-Tao Zhou
Shan-Chun Zhang
Kun Chen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveXeroderma pigmentosum complementation group C (XPC) participates in the initial recognition of DNA damage during nucleotide excision repair process in global genomic repair. Our meta-analysis was performed to evaluate the association between three polymorphisms (Lys939Gln, PAT+/- and Ala499Val) of XPC gene and risk of digestive system cancers.

methodsAll the relevant case-control studies published to April 2011 were identified through searching PubMed. Digestive system cancer risk with the three polymorphisms was estimated for each study by odds ratio (OR) with its 95% confidence interval (95% CI).

resultsWe found an increased overall risk for digestive system cancers in all three models of Lys939Gln A>C (AC/CC vs. AA: OR, 1.20; 95% CI, 1.11-1.30; CC vs. AC/AA: OR, 1.24; 95% CI, 1.11-1.39; CC vs. AA: OR, 1.36; 95% CI, 1.21-1.53). When stratified by ethnicity, results remained significant in Asian population (AC/CC vs. AA: OR, 1.18; 95% CI, 1.02-1.37; CC vs. AC/AA: OR, 1.32; 95% CI, 1.1-1.51; CC vs. AA: OR, 1.35; 95% CI, 1.08-1.70), but not for Caucasians. However for Ala499Val C>T, a significant protective effect of T allele was only observed in the dominant model. Otherwise, no significant results were observed for PAT+/-.

conclusionXPC Lys939Gln A>C polymorphism may play an important role in digestive system cancer susceptibility.

Indexed as

Digestive system cancerMeta-analysisPolymorphismXPC

Identifiers

PMID23359774
PMCPMC3555276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.